|
0
Votes
vote
FDA approves Cordis Corporation's 2.25 mm CYPHER StentCordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world... |

